Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price on May 14, 2025

Allakos Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
301082397175327,350
Market Cap Growth
--54.73%-66.71%34.92%-92.77%58.39%
Enterprise Value
-255487442836,939
Last Close Price
0.331.212.738.429.79140.00

Price Ratios

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PB Ratio
0.541.371.422.311.1911.23
P/TBV Ratio
0.541.371.422.311.1911.23

Financial Efficiency

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Debt / Equity Ratio
--0.250.160.120.07
Quick Ratio
13.544.554.679.3110.5429.35
Current Ratio
14.234.814.9210.2811.2229.81
Return on Equity (ROE)
-88.88%-93.54%-77.50%-84.65%-49.07%-26.69%
Return on Assets (ROA)
-52.64%-43.64%-38.90%-43.75%-27.05%-15.88%
Return on Invested Capital (ROIC)
-62.38%-51.35%-43.01%-47.06%-28.41%-16.33%

Yields

Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Earnings Yield
-238.22%-107.13%-77.76%-44.60%-50.75%-2.09%
FCF Yield
-301.54%--49.02%-40.19%-45.34%-1.56%
Buyback Yield / Dilution
-2.18%-2.30%-37.16%-17.56%-8.77%-9.52%
SEC Filings: 10-K · 10-Q